CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genocea Biosciences, a vaccine discovery and development company, today announced that it had hired George R. Siber, M.D. as Executive Chairman. “Dr. Siber brings a tremendous depth of knowledge to the company,” said Genocea President Robert Paull. “His vaccine experience will be instrumental in helping make our breakthrough development platform a commercial reality.”
